Skip to main content
Erschienen in: Aesthetic Plastic Surgery 6/2017

25.08.2017 | Original Article

Sexuality Among Women Treated for Breast Cancer: A Survey of Three Surgical Procedures

verfasst von: Ana Olivia Cortés-Flores, Adriana Vargas-Meza, Gilberto Morgan-Villela, Jorge Jiménez-Tornero, Carlos José Zuloaga-Fernández del Valle, Manuel Solano-Genesta, Roberto Carlos Miranda-Ackerman, Iztel Vázquez-Reyna, Luis Alberto García-González, Guillermo Alonso Cervantes-Cardona, Gabino Cervantes-Guevara, Clotilde Fuentes-Orozco, Alejandro González-Ojeda

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The quality of life of Mexican patients with breast cancer has been studied, but female sexual function has only been explored superficially. The Female Sexual Function Index (FSFI) questionnaire has been validated as a tool to measure sexual function among women with cancer. However, no study in Mexico has been published.

Purpose

To evaluate and compare female sexuality of breast cancer survivors treated with three surgical procedures.

Materials and Methods

This is a cross-sectional questionnaire survey applied in patients without active disease and free of any oncologic treatment who underwent conservative mastectomy, and mastectomy with and without reconstruction. Patients included in this study had no evidence of active disease after at least 2 years of postoperative follow-up and agreed to complete the FSFI questionnaire during a surveillance visit.

Results

Seventy-four patients were included: 37.8% had undergone conservative mastectomy, 29.7% radical mastectomy, and 32.4% radical mastectomy plus reconstruction. Patients in the radical mastectomy group were older than those in the other groups (p = 0.002). Female sexual dysfunction was observed in 34% of patients, but in patients who underwent radical mastectomy, it was 63% by contrast with 14 and 29% in women treated with conservative mastectomy and radical mastectomy with reconstruction (p = 0.001).

Conclusions

We found a lower prevalence of female sexual dysfunction in patients treated with conservative mastectomy or reconstruction after radical mastectomy. Alternatively, radical mastectomy was offered to older patients, a condition that could contribute together with a loss of female perception to a higher prevalence of sexual dysfunction.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literatur
1.
Zurück zum Zitat International Agency for Research on Cancer, World Health Organization (2013) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. http://globocan.iarc.fr. Accessed 12 June 2017 International Agency for Research on Cancer, World Health Organization (2013) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. http://​globocan.​iarc.​fr. Accessed 12 June 2017
2.
Zurück zum Zitat Rodríguez-Cuevas S, Guisa-Hohenstein F, Labastida-Almendaro S (2009) First breast cancer mammography screening program in Mexico: initial results 2005–2006. Breast J 15:623–631CrossRefPubMed Rodríguez-Cuevas S, Guisa-Hohenstein F, Labastida-Almendaro S (2009) First breast cancer mammography screening program in Mexico: initial results 2005–2006. Breast J 15:623–631CrossRefPubMed
3.
Zurück zum Zitat Gómez-Dantes O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J (2011) The health system of Mexico. Salud Publica Mex 53:s220–s232PubMed Gómez-Dantes O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J (2011) The health system of Mexico. Salud Publica Mex 53:s220–s232PubMed
4.
Zurück zum Zitat Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargallo-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A (2012) Evaluation of breast cancer treatment at a tertiary-level institution with popular health insurance in Mexico. Rev Invest Clin 64:9–16PubMed Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargallo-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A (2012) Evaluation of breast cancer treatment at a tertiary-level institution with popular health insurance in Mexico. Rev Invest Clin 64:9–16PubMed
5.
Zurück zum Zitat Cortés-Flores AO, Morgan-Villela G, Zuloaga-Fernández del Valle CJ, Jiménez-Tornero J, Juárez-Uzeta E, Urias-Valdez DP, García-González LA, Fuentes-Orozco C, Chávez-Tostado M, Macías-Amezcua MD, Garcia-Renteria J, González-Ojeda A (2014) Quality of life among women treated for breast cancer: a survey of three procedures in Mexico. Aesthetic Plast Surg 38:887–895CrossRefPubMed Cortés-Flores AO, Morgan-Villela G, Zuloaga-Fernández del Valle CJ, Jiménez-Tornero J, Juárez-Uzeta E, Urias-Valdez DP, García-González LA, Fuentes-Orozco C, Chávez-Tostado M, Macías-Amezcua MD, Garcia-Renteria J, González-Ojeda A (2014) Quality of life among women treated for breast cancer: a survey of three procedures in Mexico. Aesthetic Plast Surg 38:887–895CrossRefPubMed
6.
Zurück zum Zitat Anastasiadis AG, Davis AR, Ghafar MA, Burchardt M, Shabsigh R (2002) The epidemiology and definition of female sexual disorders. World J Urol 20:74–78CrossRefPubMed Anastasiadis AG, Davis AR, Ghafar MA, Burchardt M, Shabsigh R (2002) The epidemiology and definition of female sexual disorders. World J Urol 20:74–78CrossRefPubMed
7.
Zurück zum Zitat Basson R (2006) Clinical practice: sexual desire and arousal disorders in women. N Engl J Med 354:1497–1506CrossRefPubMed Basson R (2006) Clinical practice: sexual desire and arousal disorders in women. N Engl J Med 354:1497–1506CrossRefPubMed
8.
Zurück zum Zitat Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed
9.
Zurück zum Zitat Baser R, Li Y, Carter J (2012) Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer 118:4606–4618CrossRefPubMed Baser R, Li Y, Carter J (2012) Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer 118:4606–4618CrossRefPubMed
10.
Zurück zum Zitat Sat-Muñoz D, Contreras-Hernández I, Balderas-Peña LM, Hernández-Chávez GA, Solano-Murillo P, Mariscal-Ramírez I, Lomelí-García M, Díaz-Cortés MA, Mould-Quevedo JF, López-Mariscal AR, Prieto-Miranda SE, Morgan-Villela G (2011) Quality of life in Mexican women with breast cancer at different stages and its association with sociodemographic characteristics, comorbidities and procedural factors at the Mexican Institute of Social Security. Value Health 14(5 Suppl 1):S133–S136CrossRefPubMed Sat-Muñoz D, Contreras-Hernández I, Balderas-Peña LM, Hernández-Chávez GA, Solano-Murillo P, Mariscal-Ramírez I, Lomelí-García M, Díaz-Cortés MA, Mould-Quevedo JF, López-Mariscal AR, Prieto-Miranda SE, Morgan-Villela G (2011) Quality of life in Mexican women with breast cancer at different stages and its association with sociodemographic characteristics, comorbidities and procedural factors at the Mexican Institute of Social Security. Value Health 14(5 Suppl 1):S133–S136CrossRefPubMed
11.
Zurück zum Zitat Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargallo-Rocha E, Vilar-Compte D (2012) Validation of the Mexican-Spanish version of the EORTC QLQC30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care 21:684–691CrossRef Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargallo-Rocha E, Vilar-Compte D (2012) Validation of the Mexican-Spanish version of the EORTC QLQC30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care 21:684–691CrossRef
12.
Zurück zum Zitat Maiorino MI, Chiodini P, Bellastella G, Giugliano D, Esposito K (2016) Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the female sexual function index. Endocrine 54:329–341CrossRefPubMed Maiorino MI, Chiodini P, Bellastella G, Giugliano D, Esposito K (2016) Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the female sexual function index. Endocrine 54:329–341CrossRefPubMed
13.
Zurück zum Zitat Neto MS, de Aguiar Menezes MV, Moreira JR, García EB, Abla LE, Ferreira LM (2013) Sexuality after breast reconstruction post mastectomy. Aesthetic Plast Surg 37:643–647CrossRefPubMed Neto MS, de Aguiar Menezes MV, Moreira JR, García EB, Abla LE, Ferreira LM (2013) Sexuality after breast reconstruction post mastectomy. Aesthetic Plast Surg 37:643–647CrossRefPubMed
14.
Zurück zum Zitat Rojas K, Onstad M, Raker C, Clark MA, Stuckey A, Gass J (2017) The impact of mastectomy type on the female sexual function index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy. Breast Cancer Res Treat 163:273–279CrossRefPubMed Rojas K, Onstad M, Raker C, Clark MA, Stuckey A, Gass J (2017) The impact of mastectomy type on the female sexual function index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy. Breast Cancer Res Treat 163:273–279CrossRefPubMed
15.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241CrossRefPubMed Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241CrossRefPubMed
16.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232CrossRefPubMed Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232CrossRefPubMed
17.
Zurück zum Zitat Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150:9–16CrossRefPubMed Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150:9–16CrossRefPubMed
18.
Zurück zum Zitat Linares-Pérez N, López-Arellano O (2012) Inequalities in health in Mexico. Gac Med Mex 148:591–597PubMed Linares-Pérez N, López-Arellano O (2012) Inequalities in health in Mexico. Gac Med Mex 148:591–597PubMed
Metadaten
Titel
Sexuality Among Women Treated for Breast Cancer: A Survey of Three Surgical Procedures
verfasst von
Ana Olivia Cortés-Flores
Adriana Vargas-Meza
Gilberto Morgan-Villela
Jorge Jiménez-Tornero
Carlos José Zuloaga-Fernández del Valle
Manuel Solano-Genesta
Roberto Carlos Miranda-Ackerman
Iztel Vázquez-Reyna
Luis Alberto García-González
Guillermo Alonso Cervantes-Cardona
Gabino Cervantes-Guevara
Clotilde Fuentes-Orozco
Alejandro González-Ojeda
Publikationsdatum
25.08.2017
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 6/2017
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-017-0960-6

Weitere Artikel der Ausgabe 6/2017

Aesthetic Plastic Surgery 6/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.